These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 31519475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN, Szaflarski JP, Gidal B, VanLandingham K, Critchley D, Morrison G.
    Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
    [Abstract] [Full Text] [Related]

  • 4. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS.
    Epilepsy Curr; 2019 Sep; 19(2):93-95. PubMed ID: 30955420
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials.
    Bialer M, Perucca E.
    Epilepsia; 2020 Jun; 61(6):1082-1089. PubMed ID: 32452568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Thiele EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, Lyons PD, Taylor A, Roberts C, Sommerville K, GWPCARE4 Study Group.
    Lancet; 2018 Mar 17; 391(10125):1085-1096. PubMed ID: 29395273
    [Abstract] [Full Text] [Related]

  • 9. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
    Devinsky O, Patel AD, Thiele EA, Wong MH, Appleton R, Harden CL, Greenwood S, Morrison G, Sommerville K, GWPCARE1 Part A Study Group.
    Neurology; 2018 Apr 03; 90(14):e1204-e1211. PubMed ID: 29540584
    [Abstract] [Full Text] [Related]

  • 10. Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.
    Gunning B, Mazurkiewicz-Bełdzińska M, Chin RFM, Bhathal H, Nortvedt C, Dunayevich E, Checketts D.
    Acta Neurol Scand; 2021 Feb 03; 143(2):154-163. PubMed ID: 32969022
    [Abstract] [Full Text] [Related]

  • 11. New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
    Villanueva V, Carreño-Martínez M, Gil Nagel-Rein A, López-González FJ.
    Rev Neurol; 2021 Apr 30; 72(S01):S1-S10. PubMed ID: 33908026
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Anderson LL, Absalom NL, Abelev SV, Low IK, Doohan PT, Martin LJ, Chebib M, McGregor IS, Arnold JC.
    Epilepsia; 2019 Nov 30; 60(11):2224-2234. PubMed ID: 31625159
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome.
    Nabbout R, Arzimanoglou A, Auvin S, Berquin P, Desurkar A, Fuller D, Nortvedt C, Pulitano P, Rosati A, Soto V, Villanueva V, Cross JH.
    Seizure; 2023 Aug 30; 110():78-85. PubMed ID: 37331197
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.